Skip to main content
Erschienen in: Acta Neuropathologica 4/2009

01.10.2009 | Correspondence

Primary leptomeningeal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child

verfasst von: Sabrina Rossi, Fausto J. Rodriguez, Renan A. Mota, Angelo P. Dei Tos, Francesco Di Paola, Matteo Bendini, Silvana Agostini, Pierluigi Longatti, Robert B. Jenkins, Caterina Giannini

Erschienen in: Acta Neuropathologica | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Excerpt

Oligodendrogliomas are infiltrating gliomas typically arising in the cerebral cortex and white matter. Rare examples present with diffuse leptomeningeal involvement in the absence of a clinically/radiologically detectable intraparenchymal tumor [15, 7, 8, 10, 14, 15]. Although oligodendrogliomas are rare in children, most primary leptomeningeal oligodendrogliomas have occurred in the first decade of life (Table 1). We report the case of a 3-year-old girl, who presented with progressive regression of her ability to walk and an increase of cranial circumference. MRI showed marked hydrocephalus and diffuse leptomeningeal enhancement without supratentorial intraparenchymal lesions (Fig. 1a–c). A C3–C4 mildly enhancing 5 mm nodule was present, which could not be defined with certainty as meningeal or intraparenchymal (Fig. 1c). Cerebrospinal fluid (CSF) was xanthochromic, with high protein (177 mg/dl), normal glucose (63 mg/dl) and increased white blood cells (47 cells/mm3, 50% mononuclear). Bacterial cultures were negative, but polymerase chain reaction showed CSF positivity for M. tuberculosis. A diagnosis of basal meningitis was made and the child was unsuccessfully treated with anti-tuberculosis therapy. When a meningeal biopsy demonstrated a low-grade neuroectodermal tumor consistent with low-grade oligodendroglioma, the patient was started on chemotherapy, according to the SIOP protocol for low-grade gliomas, based on vincristine and carboplatin, changed later to vincristine and cisplatin alternating with cyclophosphamide every 6 weeks due to an allergic reaction to carboplatin. Chemotherapy was suspended at 18 months, after remarkable improvement of her clinical condition. She also received radiotherapy at the level of C2–C4, because of the gradual increase of the cervical nodule (54 Gy in 30 fractions). The child remained stable for the following 3 years, when her tumor progressed to anaplastic oligodendroglioma, as confirmed by a new biopsy of a left frontal paraventricular nodule. At this time, MRIs demonstrated multiple enhancing nodules filling the ventricles, suggesting involvement of the sub-ependymal parenchyma (Fig. 1d–f). The patient received temozolomide, but her clinical condition continued to deteriorate and she expired, 7 years from the original diagnosis.
Table 1
Cases presenting with disseminated leptomeningeal oligodendrogliomatosis
Sex/age (years)
Radiological pattern
Intraparenchymal nodule/size/site
Grade
Pathological progression
Molecular findings
Follow-up
Ref.
M/42
NA
7 mm/Tuber Cinereum
II
Not proven
NA
DOD, 1 month
[2]
F/4
NA
5 mm/chiasm
II
Not proven
NA
DOD, 3 months
[2]
M/16
NA
No
II/III
Not proven
NA
DOD, 1 year
[8]
M/31
Diffuse/nodular thickening
“Small”/Tuber Cinereum
II
Not proven
NA
DOD, 5 months
[5]
F/17
Diffuse/nodular thickening
No
II
Not proven
NA
DOD, 2 years
[4]
M/21
Diffuse/nodular thickening
No
II
Not proven
NA
DOD, 4.2 years
[14]
F/6
Diffuse/nodular thickening
No
II
Not proven
NA
DOD, 5 days
[10]
M/8
Diffuse microcystic
(after 5 years) 8 mm/spinal cord
II
Not proven
NA
DOD, 5 years
[1]
M/2.5
Diffuse/nodular thickening
Spinal cord (C6-T1)
II
Grade III (5 years)
NA
AWD, 6 years
[7]
M/2
Diffuse microcystic
No
II
Not proven
NA
AWD, 2 years
[15]
M/2
Diffuse/nodular thickening
No
II
Not proven
1p loss
AWD, 1 year
[3]
F/3
Diffuse/nodular thickening
5 mm/spinal cord
II
Grade III (6 years)
1p/19q loss
DOD, 7 years
Present case
M male, F female, NA not available, DOD dead of disease, AWD alive with disease
Literatur
1.
Zurück zum Zitat Armao DM, Stone J, Castillo M, Mitchell KM, Bouldin TW, Suzuki K et al (2000) Diffuse leptomeningeal oligodendrogliomatosis: radiologic/pathologic correlation. Am J Neuroradiol 21:1122–1126PubMed Armao DM, Stone J, Castillo M, Mitchell KM, Bouldin TW, Suzuki K et al (2000) Diffuse leptomeningeal oligodendrogliomatosis: radiologic/pathologic correlation. Am J Neuroradiol 21:1122–1126PubMed
2.
Zurück zum Zitat Beck DJK, Russell DS (1942) Oligodendrogliomatosis of the cerebrospinal fluid pathway. Brain 65:352–372CrossRef Beck DJK, Russell DS (1942) Oligodendrogliomatosis of the cerebrospinal fluid pathway. Brain 65:352–372CrossRef
3.
Zurück zum Zitat Bourne TD, Mandell JW, Matsumoto JA, Jane JA, Lopes BS (2006) Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. J Neurosurg 105:465–469PubMedCrossRef Bourne TD, Mandell JW, Matsumoto JA, Jane JA, Lopes BS (2006) Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. J Neurosurg 105:465–469PubMedCrossRef
4.
Zurück zum Zitat Chen R, Chir B, Macdonald DR, Ramsay DA (1995) Primary diffuse leptomeningeal oligodendroglioma. J Neurosurg 83:724–732PubMedCrossRef Chen R, Chir B, Macdonald DR, Ramsay DA (1995) Primary diffuse leptomeningeal oligodendroglioma. J Neurosurg 83:724–732PubMedCrossRef
5.
Zurück zum Zitat Daum S, Foncin JF, Nicolaidis S, Oeconomos D (1974) Diffuse gliomatosis of the leptomeninges and tuber oligodendroglioma. Rev Neurol 130:314–320PubMed Daum S, Foncin JF, Nicolaidis S, Oeconomos D (1974) Diffuse gliomatosis of the leptomeninges and tuber oligodendroglioma. Rev Neurol 130:314–320PubMed
6.
Zurück zum Zitat Doireau V, Grill J, Lellouch-Tubiana A et al (1999) Chemotherapy for unresectable and recurrent intramedullary glial tumors in children. Br J Cancer 81:835–840PubMedCrossRef Doireau V, Grill J, Lellouch-Tubiana A et al (1999) Chemotherapy for unresectable and recurrent intramedullary glial tumors in children. Br J Cancer 81:835–840PubMedCrossRef
7.
Zurück zum Zitat Gilmer-Hill HS, Ellis WG, Imbesi SG, Boggan JE (2000) Spinal oligodendroglioma with gliomatosis in a child. J Neurosurg 92:109–113PubMed Gilmer-Hill HS, Ellis WG, Imbesi SG, Boggan JE (2000) Spinal oligodendroglioma with gliomatosis in a child. J Neurosurg 92:109–113PubMed
8.
Zurück zum Zitat Korein J, Feigin I, Shapiro MF (1957) Oligodendrogliomatosis with intracranial hypertension. Neurology 7:589–594PubMed Korein J, Feigin I, Shapiro MF (1957) Oligodendrogliomatosis with intracranial hypertension. Neurology 7:589–594PubMed
9.
Zurück zum Zitat Kreiger PA, Okada Y, Simon S, Rorke LB, Louis DN, Golden JA (2005) Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas. Acta Neuropathol 109:387–392PubMedCrossRef Kreiger PA, Okada Y, Simon S, Rorke LB, Louis DN, Golden JA (2005) Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas. Acta Neuropathol 109:387–392PubMedCrossRef
10.
Zurück zum Zitat Ng HK, Poon WS (1999) Diffuse leptomeningeal gliomatosis with oligodendroglioma. Pathology 31:59–63PubMedCrossRef Ng HK, Poon WS (1999) Diffuse leptomeningeal gliomatosis with oligodendroglioma. Pathology 31:59–63PubMedCrossRef
11.
Zurück zum Zitat Perilongo G, Garre ML, Giangaspero F (2003) Low-grade gliomas and leptomeningeal dissemination: a poorly understood phenomenon. Childs Nerv Syst 19:197–203PubMed Perilongo G, Garre ML, Giangaspero F (2003) Low-grade gliomas and leptomeningeal dissemination: a poorly understood phenomenon. Childs Nerv Syst 19:197–203PubMed
12.
Zurück zum Zitat Pollack IF, Finkelstein SD, Burnham J et al (2003) Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort. Pediatr Neurosurg 39:114–121PubMedCrossRef Pollack IF, Finkelstein SD, Burnham J et al (2003) Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort. Pediatr Neurosurg 39:114–121PubMedCrossRef
13.
Zurück zum Zitat Raghavan R, Balani J, Perry A et al (2003) Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization. J Neuropathol Exp Neurol 62:530–537PubMed Raghavan R, Balani J, Perry A et al (2003) Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization. J Neuropathol Exp Neurol 62:530–537PubMed
14.
Zurück zum Zitat Rogers L, Estes M, Rosenbloom SA, Harrold L (1995) Primary leptomeningeal oligodendroglioma: case report. Neurosurgery 36:166–169PubMedCrossRef Rogers L, Estes M, Rosenbloom SA, Harrold L (1995) Primary leptomeningeal oligodendroglioma: case report. Neurosurgery 36:166–169PubMedCrossRef
15.
Zurück zum Zitat Stödberg T, Deniz Y, Esteitie N et al (2002) A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A. Neuropediatrics 33:266–270PubMedCrossRef Stödberg T, Deniz Y, Esteitie N et al (2002) A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A. Neuropediatrics 33:266–270PubMedCrossRef
Metadaten
Titel
Primary leptomeningeal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child
verfasst von
Sabrina Rossi
Fausto J. Rodriguez
Renan A. Mota
Angelo P. Dei Tos
Francesco Di Paola
Matteo Bendini
Silvana Agostini
Pierluigi Longatti
Robert B. Jenkins
Caterina Giannini
Publikationsdatum
01.10.2009
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 4/2009
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-009-0565-5

Weitere Artikel der Ausgabe 4/2009

Acta Neuropathologica 4/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.